There will be more than 1400 contributions,
including speakers and poster contributions. Without doubt,
you should be there, too - and do not forget to
register to the satellites as well.
The Congress will be opened by Dr
Ronald Plasterk, Minister of Education, Culture and Science
of the Netherlands, also renowned molecular and developmental
biologist publishing widely in e.g. Nature, Science, Cell
and PNAS.
A CD with all abstracts will also
be in your Congress Bag
A warm welcome to the Third World Congress
of the Board of Pharmaceutical Sciences of FIP (Fédération
Internationale Pharmaceutique or International Pharmaceutical
Federation).
The new millennium in 2000 saw the staging of the First Pharmaceutical
Sciences World Congress (PSWC2000) in San Francisco, bringing
together 2,500 pharmaceutical scientists from around the world.
The Second Congress, also with a truly global span, was held
in the Spring of 2004 in Kyoto, Japan (PSWC2004), and attracted
even more participants. The Third Congress is now to convene
in Amsterdam (PSWC2007) with the theme of:
Optimising Drug Therapy:
An Imperative for World Health
The program committee, chaired by renowned
pharmaceutical scientists, has ensured excellence in scientific
quality and a high visibility for the conference. Like the
previous two conferences, PSWC2007 will cover a broad spectrum
of topics from basic to applied and clinical sciences, addressing
timely issues of great importance to drug discovery, development,
regulation, and medication management. It will also feature
interactive round table discussions, poster sessions, a career
centre and an exhibition, and will devote significant attention
to young pharmaceutical scientists through poster and podium
presentations as well as a pre-conference meeting for graduate
students and post-doctoral fellows.
PSWC2007 is co-sponsored by many of the world’s leading
pharmaceutical science and education organisations and members
of the FIP, including the European Federation for Pharmaceutical
Sciences, EUFEPS, the American Association of Pharmaceutical
Scientists, AAPS, the Australasian Pharmaceutical Science
Association, APSA, the Academy of Pharmaceutical Sciences
of Great Britain, APSGB, the Association de Pharmacie Galénique
Industrielle, APGI, the Academy of Pharmaceutical Sciences
and Technology, Japan, APSTJ, the Controlled Release Society,
CRS, the Pharmaceutical Society of Japan, PSJ, and the Spanish
Society of Pharmaceutics and Pharmaceutical Technology (SSPPT).
In addition, an impressive number of other organisations have
pledged their active (financial) support, and they are listed
under supporting or sponsoring organisations elsewhere in
the programme.
Over 1250 abstracts have been submitted by registrants from
70 countries. In total, PSWC2007 will offer close to 1500
presentations!
Apart from the main 36 symposia, 4 satellite meetings have
been organised under the aegis of PSWC2007. These are:
Two pre-satellite meetings:
• As already mentioned, a meeting especially for Ph.D.
students and Postdocs (co-sponsored by a number of
organisations)
• A workshop on Pharmacy Curriculum Development
(organised by Utrecht University)
Two post-satellite meetings:
• A meeting on Monoclonal Antibodies
(co-sponsored by EUFEPS/EAPB/FIP/AAPS)
• A symposium on Microdialysis (Leiden
University/FIP/EUFEPS)
And, finally,
• The Mid Year Meeting 2007 of ISPE,
the International Society for Pharmacoepidemiology, which
partly overlaps with PSWC2007.
Everything is set for a highly exciting event
and an important forum for the global community of pharmaceutical
scientists!
The co-chairs forming the PSWC2007 Organising
Committee, the Scientific Advisory Board and the leadership
of FIP’s Board of Pharmaceutical Sciences welcome you
to this Third Pharmaceutical Sciences World Congress (PSWC2007)
in Amsterdam, one of the most colourful cities in the world!
On behalf of the PSWC2007 co-chairs of the Organising Committee,
Daan J. A. Crommelin, Ph.D.
Chair of the Organising Committee
Who should attend this meeting?
Pharmaceutical scientists and those involved
in the scientific and professional areas associated with the
research and development of pharmaceuticals and biologics,
health care, public policy and drug regulatory standards.